MorphoSys Aktie

39,12EUR
-1,18EUR
-2,93%
22.10.2021

WKN: 663200 / ISIN: DE0006632003

  Kaufen  
Verkaufen
oder
Werbung

MorphoSys Aktien News

21.10.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
14.10.21
MorphoSys AG Unsponsored ADR (MOR) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
13.10.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
29.09.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
20.09.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
27.08.21
Incyte (INCY), MorphoSys Win EC Approval for Lymphoma Drug (Zacks)
27.08.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
20.08.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
12.08.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
31.07.21
MorphoSys AG (MOR) Q2 2021 Earnings Call Transcript (MotleyFool)
30.07.21
MorphoSys AG : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
26.07.21
MorphoSys AG : Ad-hoc: MorphoSys AG to update financial guidance for 2021 and reduce financial liabilities (Investegate)
21.07.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
30.06.21
MorphoSys AG : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
24.06.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
07.06.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
04.06.21
Why MorphoSys Stock Sank This Week (MotleyFool)
03.06.21
Constellation (CNST) Surges on Takeover Deal With MorphoSys (Zacks)
02.06.21
MorphoSys to buy Constellation Pharma for $1.7 billion; Constellation's stock soars 61% (Market Watch)
17.05.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
14.05.21
MorphoSys AG : Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
07.05.21
MorphoSys AG (MOR) Q1 2021 Earnings Call Transcript (MotleyFool)
29.04.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
20.04.21
Incyte (INCY), MorphoSys Initiate Dosing in Lymphoma Study (Zacks)
19.04.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
17.03.21
MorphoSys AG (MOR) Q4 2020 Earnings Call Transcript (MotleyFool)
26.02.21
MorphoSys AG : Preliminary announcement of the publication of quarterly reports and quarterly/interim statements (Investegate)
26.02.21
MorphoSys AG : Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (Investegate)
25.02.21
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
26.11.20
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
18.11.20
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
12.11.20
MorphoSys AG (MOR) Q3 2020 Earnings Call Transcript (MotleyFool)
12.11.20
Incyte (INCY), Xencor and MorphoSys Ink Collaboration Deal (Zacks)
28.10.20
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
16.10.20
MorphoSys AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
06.04.20
MorphoSys says coronavirus impacting clinical studies and business (Reuters)
30.11.19
Morphosys CFO says tafasitamab drug sales potential above $1 billion: magazine (Reuters)
21.11.19
Chief scientist quits at Germany's Morphosys ahead of product launch (Reuters)
04.09.19DGAP-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
22.08.19DGAP-PVR: MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
Seite: 123456789

MorphoSys News

MorphoSys News: auf dieser Seite finden Sie alle MorphoSys News und Nachrichten zur MorphoSys Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MorphoSys News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um MorphoSys News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln